Cases That Test Your Skills

Suicidal while receiving treatment for breast cancer

Current Psychiatry. 2020 February;19(2):47-53

References

1. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19-28.
2. Thompson DS, Spanier CA, Vogel VG. The relationship between tamoxifen, estrogen, and depressive symptoms. Breast J. 1999;5(6):375-382.
3. Halbreich U. Role of estrogen in postmenopausal depression. Neurology. 1997;48(5 suppl 7):S16-S19.
4. Schiller CE, Johnson SL, Abate AC, et al. Reproductive steroid regulation of mood and behavior. Compr Physiol. 2016;6(3):1135-1160.
5. Shariff S, Cumming CE, Lees A, et al. Mood disorder in women with early breast cancer taking tamoxifen, an estradiol receptor antagonist. An expected or unexpected effect? Ann N Y Acad Sci. 1995;761:365-368.
6. Duffy LS, Greenberg DB, Younger J, et al. Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients. Psychosomatics. 1999;40(4):304-308.
7. Cathcart CK, Jones SE, Pumroy CS, et al. Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res Treat. 1993;27(3):277-281.
8. Lin J, Thompson DS. Case report: tamoxifen-induced depression. Primary Care Update for Ob/Gyns. 2001;8(5):207-208.
9. Pluss JL, DiBella NJ. Reversible central nervous system dysfunction due to tamoxifen in a patient with breast cancer. Ann Intern Med. 1984;101(5):652.
10. Bourque F, Karama S, Looper K, et al. Acute tamoxifen-induced depression and its prevention with venlafaxine. Psychosomatics. 2009;50(2):162-165.
11. De Berardis D, Brucchi M, Serroni N, et al. Successful use of agomelatine in the treatment of major depression in a woman taking tamoxifen: a case report. Clin Neuropharmacol. 2014;37(1):31-33.
12. Ito M, Baba H, Kawashima R, et al. A case of prolonged depression with tamoxifen. Japan Med Assoc J. 2006;49(4):167-172.
13. Anelli TF, Anelli A, Tran KN, et al. Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer. 1994;74(1):74-77.
14. Love RR, Cameron L, Connell BL, et al. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med. 1991;151(9):1842-1847.
15. Lee KC, Ray GT, Hunkeler EM, et al. Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics. 2007;48(3):205-210.
16. Day R, Ganz PA, Costantino JP. Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project’s Breast Cancer Prevention (P-1) Randomized Study. J Natl Cancer Inst. 2001;93(21):1615-1623.
17. Juurlink D. Revisiting the drug interaction between tamoxifen and SSRI antidepressants. BMJ. 2016;354:i5309.
18. Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771-784.
19. Buijs C, de Vries EGE, Mourits MJE, et al. The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev. 2008;34(7):640-655.

Suicidal while receiving treatment for breast cancer

References

Bottom Line

Related Resource

Drug Brand Names

Pages

Recommended Reading